Wealth Effects’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Wealth Effects's LLY Position: Q1 2026 in Review
Wealth Effects reduced its Eli Lilly (LLY) stake by 10% in Q1 2026, selling an estimated $85.2K and leaving 734 shares worth $675K. The position accounts for 0.24% of the portfolio, ranked #81.
Wealth Effects first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.48M in Q2 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Wealth Effects held 734 shares of Eli Lilly worth $675K as of Q1 2026.
- Wealth Effects sold 84 Eli Lilly shares in Q1 2026, an estimated $85.2K.
- Eli Lilly made up 0.24% of Wealth Effects's portfolio in Q1 2026, its #81 holding.
- Wealth Effects first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
- Wealth Effects's Eli Lilly position peaked at $2.48M in Q2 2024.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.